StockNews.com assumed coverage on shares of XBiotech (NASDAQ:XBIT – Free Report) in a research note published on Tuesday. The brokerage issued a sell rating on the biopharmaceutical company’s stock. XBiotech Stock Up 17.3 % Shares of XBiotech stock opened at $5.43 on Tuesday. XBiotech has a 12 month low of $3.05 and a 12 month […]

Related Keywords

, Xbiotech Company Profile , Ea Series , Virtu Financial , Xbiotech Inc , Cubist Systematic Strategies , Man Group , Free Report , Sigma Advisers , Get Free Report , True Human , Xbiotech , Nasdaq Xbit , Taxbit , Medical , Initiated Coverage , Stocknews Com ,